Method and apparatus for high throughput high efficiency transfection of cells

US11859162B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11859162-B2
Application numberUS-201916557820-A
CountryUS
Kind codeB2
Filing dateAug 30, 2019
Priority dateAug 31, 2018
Publication dateJan 2, 2024
Grant dateJan 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Transfer of genetic and other materials to cells is conducted in a hands-free, automated, high throughput, continuous process. A system using a microfluidic hydrodynamic sheath flow configuration includes arrangements for pushing cells from side streams containing a cell culture medium to a central stream containing an electroporation buffer. Electroporation can be conducted in an assembly in which two or more microfluidic channels are provided in a parallel configuration and in which various layers can be stacked together to form a laminate type structure.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for introducing a payload into cells, the method comprising: directing cells from a first incubator to an assembly that contains multiple microfluidic devices; acoustically driving cells from a cell culture medium flowing in a side stream of a sheath flow configuration, to an electroporation medium flowing through a central stream of the sheath flow configuration; applying an electric field to cells in the electroporation medium; and transferring or allowing the transfer of the payload into the cells. 2. The method of claim 1 , further comprising driving cells containing the payload from the electroporation fluid into a cell culture fluid. 3. The method of claim 2 , further comprising storing cells containing the payload in a second incubator. 4. The method of claim 1 , further comprising administering cells containing the payload to a subject in need of diagnosis, prophylaxis or treatment. 5. The method of claim 1 , wherein the payload is supplied in the electroporation medium. 6. The method of claim 1 , further comprising driving cells containing the payload from the electroporation medium to a third medium. 7. The method of claim 1 , wherein the electric field is applied by a pair of electrodes provided for each microfluidic device in the assembly. 8. A method for manufacturing cells for immunotherapy, the method comprising: acoustically transferring cells from a first buffer, wherein the first buffer is a cell culture medium, into an electroporation buffer; permeabilizing the cells by electroporation; allowing a payload to transfer into the permeabilized cells; and transferring the cells containing the payload into a second buffer, wherein, the method is conducted in an automated and continuous flow mode, wherein the electroporation buffer forms a central stream and the first buffer forms a side stream of a sheath flow configuration, and wherein, the throughput is at least 4 million cells per minute. 9. The method of claim 8 , wherein the method is conducted in an assembly comprising multiple microfluidic devices. 10. A method for introducing a payload into cells, the method comprising: flowing an electroporation medium as a central stream of a sheath flow configuration; flowing a first medium containing cells as a side stream in the sheath flow configuration; applying acoustic energy to drive cells from the first medium to the electroporation medium; applying an electric field to permeabilize the cells in the electroporation medium; and allowing the payload to transfer into the permeabilized cells. 11. The method of claim 10 , further comprising driving the cells containing the payload from the electroporation medium to the first medium. 12. The method of claim 10 , further comprising driving the cells containing the payload from the electroporation medium to a second medium, wherein the second medium is a central stream in a sheath flow configuration. 13. The method of claim 10 , further comprising applying a second acoustic energy to drive cells containing the payload from the electroporation medium to a second medium flowing as a center stream in a sheath flow configuration. 14. The method of claim 10 , wherein the method is conducted in a microfluidic device or in an assembly comprising multiple microfluidic devices. 15. The method of claim 10 , wherein the first medium containing cells is supplied from an incubator. 16. The method of claim 10 , wherein the payload is provided in the electroporation medium. 17. The method of claim 10 , wherein the method is conducted in an automated continuous flow mode. 18. The method of claim 10 , further comprising administering the cells containing the payload to a patient in need of diagnosis, prophylaxis or treatment.

Assignees

Inventors

Classifications

  • C12M23/16Primary

    Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093) · CPC title

  • Electrical or electromagnetic means, e.g. for electroporation or for cell fusion · CPC title

  • characterised by the means or forces applied to move the fluids · CPC title

  • characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

  • Additional chamber, reservoir · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11859162B2 cover?
Transfer of genetic and other materials to cells is conducted in a hands-free, automated, high throughput, continuous process. A system using a microfluidic hydrodynamic sheath flow configuration includes arrangements for pushing cells from side streams containing a cell culture medium to a central stream containing an electroporation buffer. Electroporation can be conducted in an assembly in w…
Who is the assignee on this patent?
Charles Stark Draper Laboratory Inc
What technology area does this patent fall under?
Primary CPC classification C12M23/16. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).